Related Experiment Video
Updated: May 30, 2026

13:50
A Microfluidic Device with Groove Patterns for Studying Cellular Behavior
Published on: August 30, 2007
A radial microfluidic concentration gradient generator with high-density channels for cell apoptosis assay
Chun-Guang Yang1, Ying-Fan Wu, Zhang-Run Xu
1Research Center for Analytical Sciences, Northeastern University, Shenyang 110819, China.
Lab on a Chip
|August 16, 2011
Summary
A novel microfluidic chip generates precise drug concentration gradients for high-throughput analysis of human uterine cervix cancer (HeLa) cells. This platform enables efficient drug screening and apoptosis studies in a single device.
Area of Science:
- Biotechnology
- Microfluidics
- Cancer Research
Background:
- Cancer research requires precise control over drug concentrations for accurate cellular response analysis.
- High-throughput screening methods are crucial for accelerating drug discovery and understanding treatment efficacy.
Purpose of the Study:
- To develop an integrated microfluidic concentration gradient chip for high-throughput apoptosis analysis.
- To create a platform for generating stepwise and predictable drug concentrations.
- To investigate the effects of anticancer drugs on human uterine cervix cancer (HeLa) cells.
Main Methods:
- Development of a microfluidic chip with a radial channel network for generating concentration gradients.
- Utilizing repeated splitting-and-mixing of solutions in concentric and branch channels.
- Perfusion culture of HeLa cells and drug-induced apoptosis assay using 5-fluorouracil and Cyclophosphamide at multiple concentrations.
Main Results:
- Successful generation of predictable concentration gradients across hundreds of channels.
- Demonstration of high-throughput apoptosis analysis of HeLa cells on a single chip.
- Characterization of single and combined drug effects at various concentrations.
Conclusions:
- The developed microfluidic chip provides a compact, versatile, and high-density platform for generating wide concentration ranges.
- This integrated device enables efficient, high-throughput characterization of cellular responses to drugs.
- Offers a unique platform for drug screening and personalized medicine applications in cancer research.

